Researchers report that inhibiting the methyltransferase PRMT5 with EPZ015666 keeps mouse, monkey and human spermatogonia ...

Researchers have developed a standardized protocol for the isolation and differentiation of murine jawbone osteoclasts to ...

HERVolution Therapeutics ApS, a biotechnology company pioneering human endogenous retrovirus (HERV)-targeting immunotherapies for ...

A cell study finds silk fibroin from silkworm cocoons enlarged myotubes and activated mTOR signaling in C2C12 mouse myoblasts ...

Artiva Biotherapeutics said on Tuesday it would halt the development of its experimental cell ​therapy for certain autoimmune conditions after two deaths among patients ‌who were being tested on the ...

Scientists have reversed more than 60 years of molecular aging in human blood cells, making them resemble cells from someone ...

New findings raise concerns about the potential effects of maternal COVID-19 infection on early nervous system development.

Researchers found that FGFR1 signaling helps organize bone-building material and cellular connections needed for newly ...

Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel ...

Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and ...

Aging can impair stem cell self-renewal and differentiation through molecular damage, inflammation, and changes in the surrounding tissue environment, contributing to slower repair. Experimental ...

The Arkansas Integrative Metabolic Research Center (AIMRC) will host Dr. Manolis Tzanakakis, a professor of chemical and biological engineering at Tufts University, at 11:50 a.m. on Wednesday, Oct. 28 ...